Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on November 13, 2025

November 13, 2025

La MHRA approuve la demande d’essai clinique de BetaGlue Therapeutics pour YntraDose™ dans le traitement du cancer du pancréas localement avancé non résécable (uLA-PDAC)

GlobeNewswire

November 13, 2025

SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update

GlobeNewswire

November 13, 2025

The Rumphius Foundation Awards 2025 Grants

GlobeNewswire

November 13, 2025

Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers

GlobeNewswire

November 13, 2025

GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector

GlobeNewswire

November 13, 2025

GenoSafe étend son leadership en expertise analytique avec l’ouverture de nouveaux laboratoires aux standards internationaux pour soutenir la filière des thérapies innovantes

GlobeNewswire

November 13, 2025

CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

GlobeNewswire

November 13, 2025

Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic

GlobeNewswire

November 13, 2025

Spine Wave Announces Initial Surgical Procedures with the Testa™ TP Pivoting Spacer System featuring TiCell® Nano Advanced Surface Technology

GlobeNewswire

November 13, 2025

MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial

GlobeNewswire

November 13, 2025

Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

GlobeNewswire

November 13, 2025

Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

November 13, 2025

Vivex Biologics Announces Publication of a Real-World Evidence Study Demonstrating Superior or Similar Outcomes for Cygnus® Amnion-Based Skin Substitutes in Wound Care

GlobeNewswire

November 13, 2025

Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium)

GlobeNewswire

November 13, 2025

Synergy CHC Corp. Reports Third Quarter 2025 Financial Results and its Eleventh Consecutive Quarter of Profitability

GlobeNewswire

November 13, 2025

Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights

GlobeNewswire

November 13, 2025

Arcutis Completes Enrollment in INTEGUMENT-INFANT Phase 2 Study Evaluating ZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis

GlobeNewswire

November 13, 2025

Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments

GlobeNewswire

November 13, 2025

Translational Data and Significant Pathologic Response Rates from EFTISARC-NEO Phase II Highlighted in Oral Presentation at CTOS 2025

GlobeNewswire

November 13, 2025

Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update

GlobeNewswire